Neuraminidase
This graph shows the total number of publications written about "Neuraminidase" by people in the URMC Research Network by year, and whether "Neuraminidase" was a major or minor topic of these publication.
Below are the most recent publications written about "Neuraminidase" by people in Profiles.
-
Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med. 2007 Feb; 4(2):e59.
-
Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis. 2006 Mar 15; 193(6):760-4.
-
Barroso L, Treanor J, Gubareva L, Hayden FG. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Antivir Ther. 2005; 10(8):901-10.
-
Alymova IV, Taylor G, Takimoto T, Lin TH, Chand P, Babu YS, Li C, Xiong X, Portner A. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob Agents Chemother. 2004 May; 48(5):1495-502.
-
Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA. 2000 Feb 23; 283(8):1016-24.
-
Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, Miller M, Kinnersley N, Mills RG, Ward P, Straus SE. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. 1999 Oct 6; 282(13):1240-6.
-
Tong N, Nobusawa E, Morishita M, Nakajima S, Nakajima K. M protein correlates with the receptor-binding specificity of haemagglutinin protein of reassortant influenza A (H1N1) virus. J Gen Virol. 1998 Oct; 79 ( Pt 10):2425-34.
-
Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med. 1997 Sep 25; 337(13):874-80.
-
Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA. 1996 Jan 24-31; 275(4):295-9.
-
Fernsten PD, Czyzyk JK, Mimura T, Winfield JB. Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus. Mol Biol Rep. 1994; 20(2):85-95.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
